相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Time to Consider the Exposome Hypothesis in the Development of the Obesity Pandemic
Victoria Catalan et al.
NUTRIENTS (2022)
Inhibition of CXXC5 function reverses obesity-related metabolic diseases
Seol Hwa Seo et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
Metabolic improvement and liver regeneration by inhibiting CXXC5 function for non-alcoholic steatohepatitis treatment
Seol Hwa Seo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2022)
Global pandemics interconnected - obesity, impaired metabolic health and COVID-19
Norbert Stefan et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
The Role of TCF7L2 in Type 2 Diabetes
Laura del Bosque-Plata et al.
DIABETES (2021)
Comprehensive Review of Current and Upcoming Anti-Obesity Drugs
Jang Won Son et al.
DIABETES & METABOLISM JOURNAL (2020)
Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
Alan Chait et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
CXXC5 mediates growth plate senescence and is a target for enhancement of longitudinal bone growth
Sehee Choi et al.
LIFE SCIENCE ALLIANCE (2019)
Current pharmacotherapy for obesity
Gitanjali Srivastava et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Wnt signaling in development and tissue homeostasis
Zachary Steinhart et al.
DEVELOPMENT (2018)
Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration
Gloria Alvarez-Sola et al.
GUT (2017)
Targeting of CXXC5 by a Competing Peptide Stimulates Hair Regrowth and Wound-Induced Hair Neogenesis
Soung-Hoon Lee et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss
Javier Gomez-Ambrosi et al.
CLINICAL NUTRITION (2017)
Humans and Mice Display Opposing Patterns of Browning Gene Expression in Visceral and Subcutaneous White Adipose Tissue Depots
Maria A. Zuriaga et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2017)
Small molecule inhibitors of the Dishevelled-CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy
Hyun-Yi Kim et al.
EMBO MOLECULAR MEDICINE (2016)
Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
Young-Sun Lee et al.
MEDIATORS OF INFLAMMATION (2016)
Targeting adipose tissue in the treatment of obesity-associated diabetes
Christine M. Kusminski et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
New therapeutic approaches for the treatment of obesity
Alan R. Saltiel
SCIENCE TRANSLATIONAL MEDICINE (2016)
Influencing Factors of Thermogenic Adipose Tissue Activity
Guoqing Zhang et al.
FRONTIERS IN PHYSIOLOGY (2016)
CXXC5 is a negative-feedback regulator of the Wnt/β-catenin pathway involved in osteoblast differentiation
H-Y Kim et al.
CELL DEATH AND DIFFERENTIATION (2015)
The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing
Soung-Hoon Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons
Marcelo O. Dietrich et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
A Novel Wilms Tumor 1 (WT1) Target Gene Negatively Regulates the WNT Signaling Pathway
Myoung Shin Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
CXXC5 Is a Novel BMP4-regulated Modulator of Wnt Signaling in Neural Stem Cells
Therese Andersson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Orlistat-associated adverse effects and drug interactions - A critical review
Theodosios D. Filippatos et al.
DRUG SAFETY (2008)
Interaction between the internal motif KTXXXI of Idax and mDvl PDZ domain
TBC London et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Inhibition of adipogenesis by Wnt signaling
SE Ross et al.
SCIENCE (2000)
One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor
N Finer et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Orlistat, a new lipase inhibitor for the management of obesity
AM Heck et al.
PHARMACOTHERAPY (2000)